Carnosine supplementation improves serum resistin concentrations in overweight or obese otherwise healthy adults

A pilot randomized trial

Estifanos Baye, Jozef Ukropec, Maximilian P.J. de Courten, Aya Mousa, Timea Kurdiova, Josphin Johnson, Kirsty Wilson, Magdalena Plebanski, Giancarlo Aldini, Barbara Ukropcova, Barbora de Courten

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Adipokines play an important role in the regulation of glucose metabolism. We have previously shown that carnosine supplementation in overweight or obese non-diabetic individuals improves glucose metabolism but does not change adiponectin concentrations. However, its effect on other adipokines has not been investigated. Herein we further determined the effect of carnosine supplementation on serum adipsin, resistin and leptin. Twenty-two overweight or obese otherwise healthy adults were randomly assigned to receive either 2 g of carnosine (n = 13) or identically looking placebo (n = 9) for 12 weeks. Serum adipsin, leptin and resistin were analyzed using a bead-based multiplex assay. Carnosine supplementation decreased serum resistin concentrations compared to placebo (mean change from baseline: −35 ± 83 carnosine vs. 35 ± 55 ng/mL placebo, p = 0.04). There was a trend for a reduction in serum leptin concentrations after carnosine supplementation (−76 ± 165 ng/mL carnosine vs. 20 ± 28 ng/mL placebo, p = 0.06). The changes in leptin and resistin concentrations were inversely related to the change in concentration for urinary carnosine (r = −0.72, p = 0.0002; r = −0.67, p = 0.0009, respectively), carnosine-propanal (r = −0.56, p = 0.005; r = −0.63, p = 0.001, respectively) and carnosine-propanol (r = −0.61, p = 0.002; r = −0.60, p = 0.002, respectively). There were no differences between groups in change in adipsin concentrations. Our findings show carnosine supplementation may normalize some, but not all, of the serum adipokine concentrations involved in glucose metabolism, in overweight and obese individuals. Further clinical trials with larger samples are needed to confirm these results.

Original languageEnglish
Article number1258
Number of pages10
JournalNutrients
Volume10
Issue number9
DOIs
Publication statusPublished - 7 Sep 2018

Keywords

  • Adipokines
  • Cardiovascular disease
  • Carnosine
  • Obesity
  • Type 2 diabetes

Cite this

Baye, Estifanos ; Ukropec, Jozef ; de Courten, Maximilian P.J. ; Mousa, Aya ; Kurdiova, Timea ; Johnson, Josphin ; Wilson, Kirsty ; Plebanski, Magdalena ; Aldini, Giancarlo ; Ukropcova, Barbara ; de Courten, Barbora. / Carnosine supplementation improves serum resistin concentrations in overweight or obese otherwise healthy adults : A pilot randomized trial. In: Nutrients. 2018 ; Vol. 10, No. 9.
@article{1d55b570d3a34ea9bb4ab8072fdd6c6b,
title = "Carnosine supplementation improves serum resistin concentrations in overweight or obese otherwise healthy adults: A pilot randomized trial",
abstract = "Adipokines play an important role in the regulation of glucose metabolism. We have previously shown that carnosine supplementation in overweight or obese non-diabetic individuals improves glucose metabolism but does not change adiponectin concentrations. However, its effect on other adipokines has not been investigated. Herein we further determined the effect of carnosine supplementation on serum adipsin, resistin and leptin. Twenty-two overweight or obese otherwise healthy adults were randomly assigned to receive either 2 g of carnosine (n = 13) or identically looking placebo (n = 9) for 12 weeks. Serum adipsin, leptin and resistin were analyzed using a bead-based multiplex assay. Carnosine supplementation decreased serum resistin concentrations compared to placebo (mean change from baseline: −35 ± 83 carnosine vs. 35 ± 55 ng/mL placebo, p = 0.04). There was a trend for a reduction in serum leptin concentrations after carnosine supplementation (−76 ± 165 ng/mL carnosine vs. 20 ± 28 ng/mL placebo, p = 0.06). The changes in leptin and resistin concentrations were inversely related to the change in concentration for urinary carnosine (r = −0.72, p = 0.0002; r = −0.67, p = 0.0009, respectively), carnosine-propanal (r = −0.56, p = 0.005; r = −0.63, p = 0.001, respectively) and carnosine-propanol (r = −0.61, p = 0.002; r = −0.60, p = 0.002, respectively). There were no differences between groups in change in adipsin concentrations. Our findings show carnosine supplementation may normalize some, but not all, of the serum adipokine concentrations involved in glucose metabolism, in overweight and obese individuals. Further clinical trials with larger samples are needed to confirm these results.",
keywords = "Adipokines, Cardiovascular disease, Carnosine, Obesity, Type 2 diabetes",
author = "Estifanos Baye and Jozef Ukropec and {de Courten}, {Maximilian P.J.} and Aya Mousa and Timea Kurdiova and Josphin Johnson and Kirsty Wilson and Magdalena Plebanski and Giancarlo Aldini and Barbara Ukropcova and {de Courten}, Barbora",
year = "2018",
month = "9",
day = "7",
doi = "10.3390/nu10091258",
language = "English",
volume = "10",
journal = "Nutrients",
issn = "2072-6643",
publisher = "MDPI",
number = "9",

}

Carnosine supplementation improves serum resistin concentrations in overweight or obese otherwise healthy adults : A pilot randomized trial. / Baye, Estifanos; Ukropec, Jozef; de Courten, Maximilian P.J.; Mousa, Aya; Kurdiova, Timea; Johnson, Josphin; Wilson, Kirsty; Plebanski, Magdalena; Aldini, Giancarlo; Ukropcova, Barbara; de Courten, Barbora.

In: Nutrients, Vol. 10, No. 9, 1258, 07.09.2018.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Carnosine supplementation improves serum resistin concentrations in overweight or obese otherwise healthy adults

T2 - A pilot randomized trial

AU - Baye, Estifanos

AU - Ukropec, Jozef

AU - de Courten, Maximilian P.J.

AU - Mousa, Aya

AU - Kurdiova, Timea

AU - Johnson, Josphin

AU - Wilson, Kirsty

AU - Plebanski, Magdalena

AU - Aldini, Giancarlo

AU - Ukropcova, Barbara

AU - de Courten, Barbora

PY - 2018/9/7

Y1 - 2018/9/7

N2 - Adipokines play an important role in the regulation of glucose metabolism. We have previously shown that carnosine supplementation in overweight or obese non-diabetic individuals improves glucose metabolism but does not change adiponectin concentrations. However, its effect on other adipokines has not been investigated. Herein we further determined the effect of carnosine supplementation on serum adipsin, resistin and leptin. Twenty-two overweight or obese otherwise healthy adults were randomly assigned to receive either 2 g of carnosine (n = 13) or identically looking placebo (n = 9) for 12 weeks. Serum adipsin, leptin and resistin were analyzed using a bead-based multiplex assay. Carnosine supplementation decreased serum resistin concentrations compared to placebo (mean change from baseline: −35 ± 83 carnosine vs. 35 ± 55 ng/mL placebo, p = 0.04). There was a trend for a reduction in serum leptin concentrations after carnosine supplementation (−76 ± 165 ng/mL carnosine vs. 20 ± 28 ng/mL placebo, p = 0.06). The changes in leptin and resistin concentrations were inversely related to the change in concentration for urinary carnosine (r = −0.72, p = 0.0002; r = −0.67, p = 0.0009, respectively), carnosine-propanal (r = −0.56, p = 0.005; r = −0.63, p = 0.001, respectively) and carnosine-propanol (r = −0.61, p = 0.002; r = −0.60, p = 0.002, respectively). There were no differences between groups in change in adipsin concentrations. Our findings show carnosine supplementation may normalize some, but not all, of the serum adipokine concentrations involved in glucose metabolism, in overweight and obese individuals. Further clinical trials with larger samples are needed to confirm these results.

AB - Adipokines play an important role in the regulation of glucose metabolism. We have previously shown that carnosine supplementation in overweight or obese non-diabetic individuals improves glucose metabolism but does not change adiponectin concentrations. However, its effect on other adipokines has not been investigated. Herein we further determined the effect of carnosine supplementation on serum adipsin, resistin and leptin. Twenty-two overweight or obese otherwise healthy adults were randomly assigned to receive either 2 g of carnosine (n = 13) or identically looking placebo (n = 9) for 12 weeks. Serum adipsin, leptin and resistin were analyzed using a bead-based multiplex assay. Carnosine supplementation decreased serum resistin concentrations compared to placebo (mean change from baseline: −35 ± 83 carnosine vs. 35 ± 55 ng/mL placebo, p = 0.04). There was a trend for a reduction in serum leptin concentrations after carnosine supplementation (−76 ± 165 ng/mL carnosine vs. 20 ± 28 ng/mL placebo, p = 0.06). The changes in leptin and resistin concentrations were inversely related to the change in concentration for urinary carnosine (r = −0.72, p = 0.0002; r = −0.67, p = 0.0009, respectively), carnosine-propanal (r = −0.56, p = 0.005; r = −0.63, p = 0.001, respectively) and carnosine-propanol (r = −0.61, p = 0.002; r = −0.60, p = 0.002, respectively). There were no differences between groups in change in adipsin concentrations. Our findings show carnosine supplementation may normalize some, but not all, of the serum adipokine concentrations involved in glucose metabolism, in overweight and obese individuals. Further clinical trials with larger samples are needed to confirm these results.

KW - Adipokines

KW - Cardiovascular disease

KW - Carnosine

KW - Obesity

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85053077913&partnerID=8YFLogxK

U2 - 10.3390/nu10091258

DO - 10.3390/nu10091258

M3 - Article

VL - 10

JO - Nutrients

JF - Nutrients

SN - 2072-6643

IS - 9

M1 - 1258

ER -